<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04580511</url>
  </required_header>
  <id_info>
    <org_study_id>AWR_01_CIP</org_study_id>
    <nct_id>NCT04580511</nct_id>
  </id_info>
  <brief_title>Safety and Clinical Performance of a Biological Matrix Used in Abdominal Wall Reconstruction</brief_title>
  <acronym>PMCF_AWR</acronym>
  <official_title>Safety and Clinical Performance of a Non-cross-linked Porcine Acellular Dermal Matrix Used in Abdominal Wall Reconstruction: an Observational Prospective Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meccellis Biotech</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meccellis Biotech</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The general objective of the study is to confirm the medium/long-term safety and clinical&#xD;
      performance of the CELLIS membrane used in abdominal wall reconstruction including, but not&#xD;
      limited to, ventral hernia repair and stoma closure, and to identify emerging risks in&#xD;
      comparison to the clinical data related to other types of fixation material.&#xD;
&#xD;
      The present study will be a prospective multicentric non-randomized and noncontrolled trial&#xD;
      involving 112 patients followed for 24 months. The study will be conducted in France in 3&#xD;
      investigational centres.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be prospective, multicentric, single-arm, observational (non-interventional)&#xD;
      to evaluate the safety and performance of the CELLIS membrane used in abdominal wall&#xD;
      reconstruction including, but not limited to, ventral hernia repair and stoma closure.&#xD;
&#xD;
      All evaluations will be performed and products used according to the usual practice, without&#xD;
      additional or unusual diagnostic, treatment and monitoring procedure.&#xD;
&#xD;
      The study will be conducted in France in 3 investigational centres including 112 patients&#xD;
      scheduled for an abdominal wall reconstruction.&#xD;
&#xD;
      Each patient will participate in one assessment period including a preoperative visit,&#xD;
      followed by the day of surgical procedure and a hospitalization period.&#xD;
&#xD;
      Patients will return for ambulatory visits on day 30 (+/- 7 days), on month 3 (+/- 2 weeks),&#xD;
      on month 12 (+/- 2 weeks) and on month 24 (+/-2 weeks) post-surgery.&#xD;
&#xD;
      CELLIS will be implanted by open technique following standard techniques. The membrane can be&#xD;
      used in bridged or reinforced repairs. Mesh placement can include inlay (bridging), underlay&#xD;
      intraperitoneal, sublay (retrorectus/retromuscular) positions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 4, 2020</start_date>
  <completion_date type="Anticipated">November 2024</completion_date>
  <primary_completion_date type="Anticipated">November 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of adverse events including reoperation and removal of the mesh. The main complications of interest are Surgical Site Occurrence (SSO) including Surgical Site Infection (SSI).</measure>
    <time_frame>From the surgical procedure throughout the entire 24-month follow-up period</time_frame>
    <description>Percentage</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of recurrence/incisional hernia evaluated by clinical examination and/or CT-scan</measure>
    <time_frame>Throughout the study until end of the 24-month follow-up period</time_frame>
    <description>Percentage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of recurrence/incisional hernia requiring reoperation</measure>
    <time_frame>Throughout the study until end of the 24-month follow-up period</time_frame>
    <description>Percentage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of abdominal wall laxity</measure>
    <time_frame>Throughout the study until end of the 24-month follow-up period</time_frame>
    <description>Percentage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Description of device deficiency: inadequacy of a medical device with respect to its identity, quality, durability, reliability, safety or performance. Device deficiencies include malfunctions, use errors, and inadequate labelling.</measure>
    <time_frame>During the surgical procedure</time_frame>
    <description>Summarized and listed</description>
  </secondary_outcome>
  <enrollment type="Anticipated">112</enrollment>
  <condition>Abdominal Wall Defect</condition>
  <condition>Abdominal Wall Injury</condition>
  <condition>Abdominal Hernia</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CELLIS (Porcine Acellular Dermal Matrix, PADM)</intervention_name>
    <description>Biological membrane used in abdominal reconstruction</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult with an indication of abdominal wall reconstruction including, but not limited to,&#xD;
        ventral hernia repair and stoma closure.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient aged ≥18 years,&#xD;
&#xD;
          -  Patient with an indication of abdominal wall reconstruction including, but not limited&#xD;
             to, ventral hernia repair and stoma closure,&#xD;
&#xD;
          -  Patient being informed of its participation to the study and of the follow-up visits,&#xD;
             and having no objection to the clinical data collection and medical file access,&#xD;
&#xD;
          -  Patient being informed of the porcine origin of the device in advance of the&#xD;
             procedure.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with known hypersensitivity to porcine materials,&#xD;
&#xD;
          -  Patient who is pregnant,&#xD;
&#xD;
          -  Patient having refused to participate to the study,&#xD;
&#xD;
          -  Patient refusing to return for the follow-up visits.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hassan BOUYABRINE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Montpellier, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Claire CISTERNI, PhD</last_name>
    <phone>+33 (0)6 68 13 76 26</phone>
    <email>claire.cisterni@meccellis.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Guillaume HOFMANSKI</last_name>
    <phone>+33 (0)7 61 31 11 33</phone>
    <email>guillaume.hofmanski@meccellis.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Caen Normandie, Service de Chirurgie Digestive</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gil LEBRETON, MD</last_name>
    </contact>
    <investigator>
      <last_name>Gil LEBRETON, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier La Rochelle - Ré - Aunis</name>
      <address>
        <city>La Rochelle</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hélène GIBELIN, MD</last_name>
    </contact>
    <investigator>
      <last_name>Hélène GIBELIN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Montpellier, Hôpital Saint-Eloi, Pôle digestif, Service de Chirurgie Digestive B et Transplantation</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hassan BOUYABRINE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Hassan BOUYABRINE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>October 2, 2020</study_first_submitted>
  <study_first_submitted_qc>October 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 8, 2020</study_first_posted>
  <last_update_submitted>February 23, 2021</last_update_submitted>
  <last_update_submitted_qc>February 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>abdominal wall reconstruction</keyword>
  <keyword>biological mesh</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia, Abdominal</mesh_term>
    <mesh_term>Internal Hernia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

